1. Eberbach WH (2014) Personalisierte Prävention: Wirkungen und Auswirkungen. Med R:449
2. Keil M (2015) Rechtsfragen der individualisierten Medizin. Springer, Berlin
3. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corra U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FD, Lochen ML, Lollgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van derWorp HB, vanDis I, Verschuren WM, Simone B, Document R, DeBacker G, Roffi M, Aboyans V, Bachl N, Bueno H, Carerj S, Cho L, Cox J, DeSutter J, Egidi G, Fisher M, Fitzsimons D, Franco OH, Guenoun M, Jennings C, Jug B, Kirchhof P, Kotseva K, Lip GY, Mach F, Mancia G, Bermudo FM, Mezzani A, Niessner A, Ponikowski P, Rauch B, Ryden L, Stauder A, Turc G, Wiklund O, Windecker S, Zamorano JL (2016) 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur J Prev Cardiol23(11):NP1–NP96
4. Frobose I, Wallmann-Sperlich B (2016) Der DKV report “Wie gesund lebt Deutschland” 2016. http://www.ergo.com/de/Presse/Overview/Pressemappen/DKV-Report/Publikationen-2016 . Accessed 7 Apr 2017
5. Thaler RH, Sunstein CR (2008) Nudge: improving decisions about health, wealth and happiness. Yale University Press, New Haven